Recombinant multi-species UNC13A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UNC13A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the UNC13 family. UNC13 proteins bind to phorbol esters and diacylglycerol and play important roles in neurotransmitter release at synapses. Single nucleotide polymorphisms in this gene may be associated with sporadic amyotrophic lateral sclerosis. [provided by RefSeq, Feb 2012]
The Alternative Names of target: 2410078G03Rik,Munc13-1,Protein unc-13 homolog A,UNC13A,Unc13a,Unc13h1

Target products collectionGo to UNC13A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6684-Ag-1/ GM-Tg-hg-IP6684-Ag-2 Human UNC13A protein Human
GM-Tg-rg-IP6684-Ag-1/ GM-Tg-rg-IP6684-Ag-2 Rat UNC13A protein Rat
GM-Tg-mg-IP6684-Ag-1/ GM-Tg-mg-IP6684-Ag-2 Mouse UNC13A protein Mouse
GM-Tg-cynog-IP6684-Ag-1/ GM-Tg-cynog-IP6684-Ag-2 Cynomolgus/Rhesus macaque UNC13A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6684-Ag-1/ GM-Tg-felg-IP6684-Ag-2 Feline UNC13A protein Feline
GM-Tg-cang-IP6684-Ag-1/ GM-Tg-cang-IP6684-Ag-2 Canine UNC13A protein Canine
GM-Tg-bovg-IP6684-Ag-1/ GM-Tg-bovg-IP6684-Ag-2 Bovine UNC13A protein Bovine
GM-Tg-equg-IP6684-Ag-1/ GM-Tg-equg-IP6684-Ag-2 Equine UNC13A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6684-Ag-1/ GM-Tg-hg-IP6684-Ag-2; GM-Tg-rg-IP6684-Ag-1/ GM-Tg-rg-IP6684-Ag-2;
GM-Tg-mg-IP6684-Ag-1/ GM-Tg-mg-IP6684-Ag-2; GM-Tg-cynog-IP6684-Ag-1/ GM-Tg-cynog-IP6684-Ag-2;
GM-Tg-felg-IP6684-Ag-1/ GM-Tg-felg-IP6684-Ag-2; GM-Tg-cang-IP6684-Ag-1/ GM-Tg-cang-IP6684-Ag-2;
GM-Tg-bovg-IP6684-Ag-1/ GM-Tg-bovg-IP6684-Ag-2; GM-Tg-equg-IP6684-Ag-1/ GM-Tg-equg-IP6684-Ag-2
Products Name UNC13A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name UNC13A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UNC13A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.